378-26243-43013
3 vaccinations
5 coded responses
27 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 907 / CA
- Registered
- 2021-01-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-24
Registered in v-safe
-
2021-01-24
Dose 1 — Pfizer-BioNTech
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-07
-
2021-02-14
Dose 2 — Pfizer-BioNTech
- 2021-02-14
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-16
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Secretion discharge — Feeling: GoodFree text: Sore throat with mucusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-03-21
- 2021-03-28
- 2021-05-17
- 2021-08-15
-
2022-02-14
Survey response — 12 months, dose 2MedDRA: Haematoma — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HematomaMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-17
-
2022-02-22
Call successfulParticipant prefers to complete VAERS report online
-
2022-06-05
Dose 3 — Pfizer-BioNTech
- 2022-12-06
-
2023-06-07
Survey response — 12 months, dose 3MedDRA: Bone pain — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-24 | Pfizer-BioNTech | |
| 2 | 2021-02-14 | Pfizer-BioNTech | |
| 3 | 2022-06-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-14 | Successful 2022-02-22 |
Participant prefers to complete VAERS report online |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Systemic reaction (other): Sore throat with mucus
Systemic reaction (other): Sore throat
Release 11 — 12 months, dose 2
Symptoms: Hematoma
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bone pain | · | · | ✓ |
| SD | Haematoma | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Secretion discharge | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release